SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001561743-16-000048
Filing Date
2016-03-02
Accepted
2016-03-02 16:05:32
Documents
3
Period of Report
2016-02-25
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K a8-k322016.htm 8-K 25487
2 PRESS RELEASE pr_4q2015financialresults.htm EX-99.1 21479
3 pr4q2015financialresu_image1.gif GRAPHIC 34855
  Complete submission text file 0001561743-16-000048.txt   96344
Mailing Address 1555 BAYSHORE HIGHWAY, SUITE 200 BURLINGAME CA 94010
Business Address 1555 BAYSHORE HIGHWAY, SUITE 200 BURLINGAME CA 94010 650-701-7901
Kindred Biosciences, Inc. (Filer) CIK: 0001561743 (see all company filings)

IRS No.: 461160142 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36225 | Film No.: 161477103
SIC: 2834 Pharmaceutical Preparations